62713-102 NDC - ALLERGENA (HOMEOPATHIC SUBLINGUAL IMMUNOTHERAPY)

Drug Information

  • Product NDC: 62713-102
  • Proprietary Name: Allergena
  • Non Proprietary Name: Homeopathic Sublingual Immunotherapy
  • Active Ingredient(s): 30 [hp_X]/mL AMARANTHUS RETROFLEXUS POLLEN; 30 [hp_X]/mL AMBROSIA ARTEMISIIFOLIA POLLEN; 30 [hp_X]/mL ARTEMISIA VULGARIS POLLEN; 3 [hp_X]/mL BAPTISIA TINCTORIA ROOT; 30 [hp_X]/mL BETULA PAPYRIFERA POLLEN; 3 [hp_X]/mL CALENDULA OFFICINALIS FLOWERING TOP; 30 [hp_X]/mL CYNODON DACTYLON POLLEN; 9 [hp_X]/mL DELPHINIUM STAPHISAGRIA SEED; 30 [hp_X]/mL DERMATOPHAGOIDES FARINAE; 30 [hp_X]/mL DERMATOPHAGOIDES PTERONYSSINUS; 3 [hp_X]/mL ECHINACEA, UNSPECIFIED; 3 [hp_X]/mL FENUGREEK LEAF; 3 [hp_X]/mL GOLDENSEAL; 30 [hp_X]/mL JUNIPERUS ASHEI POLLEN; 30 [hp_X]/mL LOLIUM PERENNE POLLEN; 3 [hp_X]/mL MYRRH; 30 [hp_X]/mL PASPALUM NOTATUM POLLEN; 30 [hp_X]/mL PHLEUM PRATENSE POLLEN; 3 [hp_X]/mL PHYTOLACCA AMERICANA ROOT; 30 [hp_X]/mL POA ANNUA POLLEN; 30 [hp_X]/mL QUERCUS RUBRA POLLEN; 30 [hp_X]/mL SALSOLA TRAGUS POLLEN; 6 [hp_X]/mL TOXICODENDRON PUBESCENS LEAF; 3 [hp_X]/mL URTICA URENS
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Antigens; Dermatophagoides [CS]; Antigens; Dermatophagoides [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Insect Proteins [CS]; Insect Proteins [CS]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Standardized Insect Allergenic Extract [EPC]; Standardized Insect Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Meditrend, Inc. DBA Progena Professional Formulations
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:4/1/2026

Package Information

No. Package Code Package Description Billing Unit
162713-102-0130 mL in 1 BOTTLE, DROPPER (62713-102-01)

NDC Record

Field Name Field Value Definition
PRODUCT NDC62713-102The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEAllergenaThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXfor PetsA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
NON PROPRIETARY NAMEHomeopathic Sublingual ImmunotherapyThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE4/1/2026This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEMeditrend, Inc. DBA Progena Professional FormulationsName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEAMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; ARTEMISIA VULGARIS POLLEN; BAPTISIA TINCTORIA ROOT; BETULA PAPYRIFERA POLLEN; CALENDULA OFFICINALIS FLOWERING TOP; CYNODON DACTYLON POLLEN; DELPHINIUM STAPHISAGRIA SEED; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; ECHINACEA, UNSPECIFIED; FENUGREEK LEAF; GOLDENSEAL; JUNIPERUS ASHEI POLLEN; LOLIUM PERENNE POLLEN; MYRRH; PASPALUM NOTATUM POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; POA ANNUA POLLEN; QUERCUS RUBRA POLLEN; SALSOLA TRAGUS POLLEN; TOXICODENDRON PUBESCENS LEAF; URTICA URENSAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH30; 30; 30; 3; 30; 3; 30; 9; 30; 30; 3; 3; 3; 30; 30; 3; 30; 30; 3; 30; 30; 30; 6; 3 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 5/7/2026

Previous Code
Next Code